Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-09

Clinical Trial Update: Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 Pfizer-sponsored trial evaluating the efficacy and safety of etanercept in combination with acitretin in Korean patients with moderate to severe psorias…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)
  • Soriatane (acitretin)

Snippet

Sponsor: Pfizer | Conditions: Moderate to Severe Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2012-04-09